Literature DB >> 7769660

Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination.

W Yang1, J Summers.   

Abstract

Linear hepadnavirus DNA in primary hepatocyte cultures efficiently participates in intra- and intermolecular nonhomologous recombination at its ends. The products of this recombination are (i) monomeric covalently closed circular DNAs (cccDNAs) with deletions and insertions around the site of joining and (ii) oligomeric forms in which monomers are joined near the ends in random orientation. A fraction of monomeric cccDNAs can serve as intermediates in further DNA replication through at least five generations of nonhomologous recombination in a process we call illegitimate replication. We suggest that the monomeric and oligomeric linear DNAs produced by illegitimate replication may be precursors of the integrated and other high-molecular-weight hepadnaviral DNA forms seen in chronic infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769660      PMCID: PMC189136          DOI: 10.1128/JVI.69.7.4029-4036.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Mechanism of translation of the hepadnaviral polymerase (P) gene.

Authors:  L J Chang; D Ganem; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis.

Authors:  J M Lien; C E Aldrich; W S Mason
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Synthesis of hepadnavirus particles that contain replication-defective duck hepatitis B virus genomes in cultured HuH7 cells.

Authors:  A L Horwich; K Furtak; J Pugh; J Summers
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification.

Authors:  J Summers; P M Smith; A L Horwich
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Infection and uptake of duck hepatitis B virus by duck hepatocytes maintained in the presence of dimethyl sulfoxide.

Authors:  J C Pugh; J W Summers
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

6.  Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation.

Authors:  J M Lien; D J Petcu; C E Aldrich; W S Mason
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway.

Authors:  T T Wu; L Coates; C E Aldrich; J Summers; W S Mason
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

8.  Efficient duck hepatitis B virus production by an avian liver tumor cell line.

Authors:  L D Condreay; C E Aldrich; L Coates; W S Mason; T T Wu
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  Comparative sequence analysis of duck and human hepatitis B virus genomes.

Authors:  R Sprengel; C Kuhn; H Will; H Schaller
Journal:  J Med Virol       Date:  1985-04       Impact factor: 2.327

10.  Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH.

Authors:  T Kawaguchi; K Nomura; Y Hirayama; T Kitagawa
Journal:  Cancer Res       Date:  1987-08-15       Impact factor: 12.701

View more
  50 in total

1.  Small DNA hairpin negatively regulates in situ priming during duck hepatitis B virus reverse transcription.

Authors:  Jeffrey W Habig; Daniel D Loeb
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Mutations that increase in situ priming also decrease circularization for duck hepatitis B virus.

Authors:  D D Loeb; R Tian
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor.

Authors:  W Yang; J Summers
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration.

Authors:  Colin A Bill; Jesse Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-16       Impact factor: 11.205

Review 5.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

Review 6.  Animal models and the molecular biology of hepadnavirus infection.

Authors:  William S Mason
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

Review 7.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

8.  Integrated hepatitis B virus DNA preserves the binding sequence of transcription factor Yin and Yang 1 at the virus-cell junction.

Authors:  M Nakanishi-Matsui; Y Hayashi; Y Kitamura; K Koike
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir.

Authors:  William S Mason; Chunxiao Xu; Huey Chi Low; Jeffry Saputelli; Carol E Aldrich; Catherine Scougall; Arend Grosse; Richard Colonno; Sam Litwin; Allison R Jilbert
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 10.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.